Advancing personalized medicine requires close collaboration across stakeholders

The development of personalized medicine depends on collaboration among multiple stakeholders, who must navigate uncertainty while shaping expectations of future value.

A recent study from the University of Eastern Finland published in Innovation examines how companies take part in this process and what kinds of challenges and opportunities emerge. ...